Physician profile
Matthew S Smith
NPI 1306580873
$2,398.28
in general payments reported to CMS, 2019-2025
8 companies · $2,127 in 2025
The $2,127 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $33.20 · 2024: $238 · 2025: $2,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,185 · Food and Beverage: $1,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,185.36 |
| Food and Beverage | $1,179.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,349.64 | 2024-2025 | Healix Knotless Peek |
| Medical Device Business Services, INC. | $304.60 | 2025 | Inhance |
| Stryker Corporation | $142.72 | 2025 | Na, Gamma, Aequalis Perform Reversed |
| Zimmer Biomet Holdings, INC. | $141.70 | 2025 | |
| Fortis Surgical, LLC | $134.20 | 2024-2025 | |
| Globus Medical, INC. | $127.90 | 2025 | Reline, Fortify |
| Biomarin Pharmaceutical INC. | $99.96 | 2025 | Voxzogo 1.2mg |
| Anika Therapeutics, INC. | $64.36 | 2024 | Ovomotion, Anchors, Integrity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.